167 related articles for article (PubMed ID: 19587312)
1. Matrix metalloprotease-9 inhibition improves amyloid beta-mediated cognitive impairment and neurotoxicity in mice.
Mizoguchi H; Takuma K; Fukuzaki E; Ibi D; Someya E; Akazawa KH; Alkam T; Tsunekawa H; Mouri A; Noda Y; Nabeshima T; Yamada K
J Pharmacol Exp Ther; 2009 Oct; 331(1):14-22. PubMed ID: 19587312
[TBL] [Abstract][Full Text] [Related]
2. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment.
Hernández-Guillamon M; Delgado P; Ortega L; Pares M; Rosell A; García-Bonilla L; Fernández-Cadenas I; Borrell-Pagès M; Boada M; Montaner J
J Neurosci Res; 2009 Jul; 87(9):2115-25. PubMed ID: 19235898
[TBL] [Abstract][Full Text] [Related]
3. Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice.
Alkam T; Nitta A; Mizoguchi H; Saito K; Seshima M; Itoh A; Yamada K; Nabeshima T
Behav Brain Res; 2008 May; 189(1):100-6. PubMed ID: 18325608
[TBL] [Abstract][Full Text] [Related]
4. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.
Baig S; Kehoe PG; Love S
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):205-15. PubMed ID: 17971072
[TBL] [Abstract][Full Text] [Related]
5. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
Lu P; Mamiya T; Lu LL; Mouri A; Niwa M; Hiramatsu M; Zou LB; Nagai T; Ikejima T; Nabeshima T
J Pharmacol Exp Ther; 2009 Oct; 331(1):319-26. PubMed ID: 19638571
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of Glycyrrhiza uralensis Fisch. on the cognitive deficits caused by beta-amyloid peptide 25-35 in young mice.
Ahn J; Um M; Choi W; Kim S; Ha T
Biogerontology; 2006 Aug; 7(4):239-47. PubMed ID: 16821116
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of Polygonum multiflorum Thunb on amyloid beta-peptide 25-35 induced cognitive deficits in mice.
Um MY; Choi WH; Aan JY; Kim SR; Ha TY
J Ethnopharmacol; 2006 Mar; 104(1-2):144-8. PubMed ID: 16219438
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-Ile-Gly-Leu protects neurons from Abeta(1-42) induced toxicity in vitro and in V337M human tau-expressing mice.
Xiong ZM; Kitagawa K; Nishiuchi Y; Kimura T; Nakamura T; Inagaki C
Life Sci; 2009 Jan; 84(5-6):132-8. PubMed ID: 19087881
[TBL] [Abstract][Full Text] [Related]
9. The extensive nitration of neurofilament light chain in the hippocampus is associated with the cognitive impairment induced by amyloid beta in mice.
Alkam T; Nitta A; Mizoguchi H; Itoh A; Murai R; Nagai T; Yamada K; Nabeshima T
J Pharmacol Exp Ther; 2008 Oct; 327(1):137-47. PubMed ID: 18621989
[TBL] [Abstract][Full Text] [Related]
10. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice.
Cho JY; Kim HS; Kim DH; Yan JJ; Suh HW; Song DK
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):901-7. PubMed ID: 15970368
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage.
Lee JM; Yin K; Hsin I; Chen S; Fryer JD; Holtzman DM; Hsu CY; Xu J
J Neurol Sci; 2005 Mar; 229-230():249-54. PubMed ID: 15760647
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains.
Kuang X; Du JR; Chen YS; Wang J; Wang YN
Pharmacol Biochem Behav; 2009 Jun; 92(4):635-41. PubMed ID: 19324070
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo.
Elvang AB; Volbracht C; Pedersen LØ; Jensen KG; Karlsson JJ; Larsen SA; Mørk A; Stensbøl TB; Bastlund JF
J Neurochem; 2009 Sep; 110(5):1377-87. PubMed ID: 19519664
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy.
Lee JM; Yin KJ; Hsin I; Chen S; Fryer JD; Holtzman DM; Hsu CY; Xu J
Ann Neurol; 2003 Sep; 54(3):379-82. PubMed ID: 12953271
[TBL] [Abstract][Full Text] [Related]
16. Role of oxidative stress on beta-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants.
Montiel T; Quiroz-Baez R; Massieu L; Arias C
Exp Neurol; 2006 Aug; 200(2):496-508. PubMed ID: 16626708
[TBL] [Abstract][Full Text] [Related]
17. Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes.
Guo S; Wang S; Kim WJ; Lee SR; Frosch MP; Bacskai BJ; Greenberg SM; Lo EH
Brain Res; 2006 Sep; 1111(1):222-6. PubMed ID: 16919608
[TBL] [Abstract][Full Text] [Related]
18. A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta(25-35).
Alkam T; Nitta A; Mizoguchi H; Itoh A; Nabeshima T
Behav Brain Res; 2007 Jun; 180(2):139-45. PubMed ID: 17420060
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy.
Matsumoto Y; Park IK; Kohyama K
J Immunol; 2009 Oct; 183(7):4773-81. PubMed ID: 19734212
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment.
Mamo JC; Jian L; James AP; Flicker L; Esselmann H; Wiltfang J
Ann Clin Biochem; 2008 Jul; 45(Pt 4):395-403. PubMed ID: 18583625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]